-
Sale!
$1,799.99 Original price was: $1,799.99.$899.99Current price is: $899.99.
Saxenda® (Liraglutide) Injection 6 mg/mL – 3 mL Pre-Filled Pens (5-Pack, RX Only)
Refrigeration Required
At Weight Loss RX, we offer FDA-approved prescription medications designed to support safe, medically supervised weight loss.
Saxenda® (liraglutide) is a once-daily injectable prescription medication specifically approved for chronic weight management in adults with obesity or excess weight. It is indicated for individuals with a BMI of 30 or higher, or BMI of 27 or higher when accompanied by weight-related conditions such as high blood pressure, type 2 diabetes, or high cholesterol.
-
Sale!
$1,574.99 Original price was: $1,574.99.$787.49Current price is: $787.49.
Zepbound® (Tirzepatide) Injection 12.5 mg/0.5 mL – Pen-Style Prefilled Syringes (4-Pack, RX Only)
Refrigeration Required – Recipient Must Be Available for Delivery
At Weight Loss RX, we provide access to FDA-approved prescription medications used in medically supervised weight management programs.
Zepbound® (tirzepatide) is a once-weekly injectable prescription medication approved for chronic weight management, not diabetes treatment. It is indicated for adults with obesity (BMI ≥30) or overweight (BMI ≥27) when accompanied by at least one weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes. Zepbound is manufactured by Eli Lilly and Company and received FDA approval in 2023 specifically for weight loss.
-
Sale!
$1,474.99 Original price was: $1,474.99.$737.49Current price is: $737.49.
Zepbound® (Tirzepatide) Injection 15 mg/0.5 mL – Pen-Style Prefilled Syringes (4-Pack, RX Only)
Refrigeration Required – Recipient Must Be Available for Delivery
At Weight Loss RX, we provide access to FDA-approved prescription medications used in medically supervised weight management programs.
Zepbound® (tirzepatide) is a once-weekly injectable prescription medication approved for chronic weight management, not for the treatment of diabetes. It is indicated for adults with obesity (BMI ≥30) or overweight (BMI ≥27) who also have at least one weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes. Zepbound is manufactured by Eli Lilly and Company and was FDA-approved in 2023 specifically for weight loss.
